Radiotherapy and Oncology

Article	Citations
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group	183
Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance	181
Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial	129
A physicochemical model of reaction kinetics supports peroxyl radical recombination as the main determinant of the FLASH effect	116
What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans	110
Metrics to evaluate the performance of auto-segmentation for radiation treatment planning: A critical review	110
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma	105
A deep learning-based auto-segmentation system for organs-at-risk on whole-body computed tomography images for radiation therapy	94
Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma	92
Radiotherapy Treatment plannINg study Guidelines (RATING): A framework for setting up and reporting on scientific treatment planning studies	91
Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)	79
The tubarial salivary glands: A potential new organ at risk for radiotherapy	79
In vivo validation and tissue sparing factor for acute damage of pencil beam scanning proton FLASH	75
Mechanisms of radiation-induced endothelium damage: Emerging models and technologies	74
A deep learning approach to generate synthetic CT in low field MR-guided adaptive radiotherapy for abdominal and pelvic cases	69
Deep learning-based synthetic CT generation for paediatric brain MR-only photon and proton radiotherapy	69
Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment	68
Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience	68
May oxygen depletion explain the FLASH effect? A chemical track structure analysis	67
Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results	67
A systematic review on the usage of averaged LET in radiation biology for particle therapy	64
ADC measurements on the Unity MR-linac – A recommendation on behalf of the Elekta Unity MR-linac consortium	63
Clinical evaluation of atlas- and deep learning-based automatic segmentation of multiple organs and clinical target volumes for breast cancer	63
Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes	62
Clinical implementation of deep learning contour autosegmentation for prostate radiotherapy	62

First magnetic resonance imaging-guided cardiac radioablation of sustained ventricular tachycardia	62
Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction	60
Development and validation of a deep learning algorithm for auto-delineation of clinical target volume and organs at risk in cervical cancer radiotherapy	57
IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer	56
Improvement of prediction and classification performance for gamma passing rate by using plan complexity and dosiomics features	55
Deep learning-based auto-segmentation of organs at risk in high-dose rate brachytherapy of cervical cancer	55
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma	55
Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials	53
Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey	53
First demonstration of the FLASH effect with ultrahigh dose rate high-energy X-rays	52
ESTRO ACROP guideline for target volume delineation of skull base tumors	52
Dose prediction with deep learning for prostate cancer radiation therapy: Model adaptation to different treatment planning practices	51
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial	50
The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review	49
Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma	49
Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977–2005	48
Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?	47
Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits	46
FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model	46
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus	44
68Ga-FAPI-PET/CT improves diagnostic staging and radiotherapy planning of adenoid cystic carcinomas – Imaging analysis and histological validation	43
Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer	42
ESTRO ACROP guidelines for target volume definition in pancreatic cancer	42
Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment	42
Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon th	42
Clinical paradigms and challenges in surface guided radiation therapy: Where do we go from here?	42
MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapy	42
GEC-ESTRO ACROP prostate brachytherapy guidelines	41
Current delivery limitations of proton PBS for FLASH	41
68Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer	40
Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part I: Intra-fraction breathing motion management	40
Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis	40
Deep learning-enabled MRI-only photon and proton therapy treatment planning for paediatric abdominal tumours	40
Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer	40
Multicentre, deep learning, synthetic-CT generation for ano-rectal MR-only radiotherapy treatment planning	39
ESTRO-ACROP guideline on surface guided radiation therapy	39
Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan	38
ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology	38
A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy	38
Grand challenges for medical physics in radiation oncology	38
Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma – How safe are protons?	37
Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems	37
ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases	36
Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer – The RAPIDO trial	36
Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis	36
Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?	36
Deep learning prediction of proton and photon dose distributions for paediatric abdominal tumours	35
MetNet: Computer-aided segmentation of brain metastases in post-contrast T1-weighted magnetic resonance imaging	35
Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation	35
ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases	35

The role of computational methods for automating and improving clinical target volume definition	34
A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome	34
Pencil beam scanning proton FLASH maintains tumor control while normal tissue damage is reduced in a mouse model	34
Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: A population-based Danish Breast Cancer Group study	34
Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology	33
Prediction of pseudoprogression and long-term outcome of vestibular schwannoma after Gamma Knife radiosurgery based on preradiosurgical MR radiomics	32
Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy	32
Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma	31
Beam pulse structure and dose rate as determinants for the flash effect observed in zebrafish embryo	31
An especially high rate of radiation pneumonitis observed in patients treated with thoracic radiotherapy and simultaneous osimertinib	31
Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer	31
A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE)	30
Electron dose rate and oxygen depletion protect zebrafish embryos from radiation damage	30
Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations	30
Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [18F]FMISO PET/CT	30
Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review	30
Current practice in proton therapy delivery in adult cancer patients across Europe	30
Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)	29
Prognostic value of multiparametric MRI-based radiomics model: Potential role for chemotherapeutic benefits in locally advanced rectal cancer	29
Hypofractionated radiation therapy for breast cancer: Preferences amongst radiation oncologists in Europe – Results from an international survey	29
Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer	28
Head and neck cancer patients under (chemo-)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial	28
Towards the clinical implementation of intensity-modulated proton therapy for thoracic indications with moderate motion: Robust optimised plan evaluation by means of patient and machine specific infor	28
Taste dysfunction following radiotherapy to the head and neck: A systematic review	28
Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) – An analysis of UK’s largest cohort of lung SABR patients	28
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study	28
Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes	27
Pre-clinical validation of a novel system for fully-automated treatment planning	27
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases	27
Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort	27
Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial	27
Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach	27
Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis	27
Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease – A systematic review	26
Cardiac sub-volume targeting demonstrates regional radiosensitivity in the mouse heart	26
Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study	26
A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer	26
Distance to isocenter is not associated with an increased risk for local failure in LINAC-based single-isocenter SRS or SRT for multiple brain metastases	26
Urethral and bladder dose–effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial	26
Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer	26
An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic color	26
Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03	26
Significant correlation between gross tumor volume (GTV) D98% and local control in multifraction stereotactic radiotherapy (MF-SRT) for unresected brain metastases	26
How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy	26
Head and neck IMPT probabilistic dose accumulation: Feasibility of a 2 mm setup uncertainty setting	26
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis	25
Deciphering the epigenetic network in cancer radioresistance	25
Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study	25
Identification of treatment error types for lung cancer patients using convolutional neural networks and EPID dosimetry	25
Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study	25
Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients	25
Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial	24
Deep learning for elective neck delineation: More consistent and time efficient	24
How do patient-reported outcomes compare with clinician assessments? A prospective study of radiation dermatitis in breast cancer	24
Radiotherapy as nose preservation treatment strategy for cancer of the nasal vestibule: The Dutch experience	24
First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer	24
FLASH radiotherapy: Considerations for multibeam and hypofractionation dose delivery	24
Hematological toxicity in patients with solid malignant tumors treated with radiation – Temporal analysis, dose response and impact on survival	24
Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma	24
Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency	24
Magnetic resonance imaging (MRI) guided proton therapy: A review of the clinical challenges, potential benefits and pathway to implementation	24
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer	24
Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy	24
Rapid 4D-MRI reconstruction using a deep radial convolutional neural network: Dracula	24
Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control	24
Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study	23
Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients	23
Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies	23
Risk of ischaemic cerebrovascular events in head and neck cancer patients is associated with carotid artery radiation dose	23
CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study	23
ESTRO-ACROP guideline: Recommendations on implementation of breath-hold techniques in radiotherapy	23
Training, validation, and clinical implementation of a deep-learning segmentation model for radiotherapy of loco-regional breast cancer	23
Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma	23
FLASH radiotherapy treatment planning and models for electron beams	23
First experimental demonstration of VMAT combined with MLC tracking for single and multi fraction lung SBRT on an MR-linac	23
Tricks and tips for target volume definition and delineation in breast cancer: Lessons learned from ESTRO breast courses	23
Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer	23
Stereotactic body radiotherapy to treat breast cancer oligometastases: A systematic review with meta-analysis	22
Value-based radiotherapy: A new chapter of the ESTRO-HERO project	22
Towards homogenization of total body irradiation practices in pediatric patients across SIOPE affiliated centers. A survey by the SIOPE radiation oncology working group	22

Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma	22
Comparing radiolytic production of H2O2 and development of Zebrafish embryos after ultra high dose rate exposure with electron and transmission proton beams	22
The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis	22
Predicting outcomes in anal cancer patients using multi-centre data and distributed learning – A proof-of-concept study	22
From multisource data to clinical decision aids in radiation oncology: The need for a clinical data science community	22
Proton vs photon: A model-based approach to patient selection for reduction of cardiac toxicity in locally advanced lung cancer	22
Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study	22
Experimental assessment of inter-centre variation in stopping-power and range prediction in particle therapy	22
Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder	21
CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy	21
Intensified systemic therapy and stereotactic ablative radiotherapy dose for patients with unresectable pancreatic adenocarcinoma	21
Re-irradiation in the thorax – An analysis of efficacy and safety based on accumulated EQD2 doses	21
Commissioning and clinical implementation of an Autoencoder based Classification-Regression model for VMAT patient-specific QA in a multi-institution scenario	21
Applicability and usage of dose mapping/accumulation in radiotherapy	21
Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic cancer	21
Proton therapy for selected low grade glioma patients in the Netherlands	21
The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma	21
Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial	21
The use of pentoxifylline, tocopherol and clodronate in the management of osteoradionecrosis of the jaws	21
Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncology	21
Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures	21
Pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis	21
Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion	21
Multifactorial risk factors for mortality after chemotherapy and radiotherapy for non-small cell lung cancer	20
Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer	20
The role of surface-guided radiation therapy for improving patient safety	20
Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy	20
Deep learning model for automatic contouring of cardiovascular substructures on radiotherapy planning CT images: Dosimetric validation and reader study based clinical acceptability testing	20
Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters	20
Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapy	20
Clinical necessity of multi-image based (4DMIB) optimization for targets affected by respiratory motion and treated with scanned particle therapy – A comprehensive review	20
Online adaptive radiotherapy of anal cancer: Normal tissue sparing, target propagation methods, and first clinical experience	20
Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patients	20
MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose	20
Early health economic analysis of 1.5 T MRI-guided radiotherapy for localized prostate cancer: Decision analytic modelling	20
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma	20
Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiot	20
Dose prediction via distance-guided deep learning: Initial development for nasopharyngeal carcinoma radiotherapy	20
Thermoacoustic range verification during pencil beam delivery of a clinical plan to an abdominal imaging phantom	19
Intrafraction motion during partial breast irradiation depends on treatment time	19
Dosimetric influence of deformable image registration uncertainties on propagated structures for online daily adaptive proton therapy of lung cancer patients	19
Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer	19
Same-day adaptive palliative radiotherapy without prior CT simulation: Early outcomes in the FAST-METS study	19
Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost	19
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer	19
CT-based radiomics analysis in the prediction of response to neoadjuvant chemotherapy in locally advanced gastric cancer: A dual-center study	19
Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy	19
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023	19
Dosimetric parameters associated with radiation-induced esophagitis in breast cancer patients undergoing regional nodal irradiation	19
Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1	19
Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia	19
Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities	18
Clinical implementation of 3D in vivo dosimetry for abdominal and pelvic stereotactic treatments	18
Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac	18
Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation	18
LITE SABR M1: A phase I trial of Lattice stereotactic body radiotherapy for large tumors	18
Treatment planning considerations for the development of FLASH proton therapy	18
Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma	18
RealDRR – Rendering of realistic digitally reconstructed radiographs using locally trained image-to-image translation	18
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial	18
Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac	18
Ultra-hypofractionated radiotherapy for low- and intermediate risk prostate cancer: High-dose-rate brachytherapy vs stereotactic ablative radiotherapy	18
Deep learning-based accurate delineation of primary gross tumor volume of nasopharyngeal carcinoma on heterogeneous magnetic resonance imaging: A large-scale and multi-center study	18
Re-irradiation for recurrent high grade glioma (HGG) patients: Results of a single arm prospective phase 2 study	18
Technical feasibility and clinical evaluation of 4D-MRI guided liver SBRT on the MR-linac	18
Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation	18
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer	18
A multi-institutional assessment of COVID-19-related risk in radiation oncology	17
HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis	17
Model based patient pre-selection for intensity-modulated proton therapy (IMPT) using automated treatment planning and machine learning	17
The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial	17
Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting	17
Phantom-based quality assurance for multicenter quantitative MRI in locally advanced cervical cancer	17
Design and validation of a dosimetric comparison scheme tailored for ultra-high dose-rate electron beams to support multicenter FLASH preclinical studies	17
Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India	17
Assessing the role of radiotherapy in patients with refractory or relapsed high-grade B-cell lymphomas treated with CAR T-cell therapy	17
Deep regional hyperthermia with preoperative radiochemotherapy in locally advanced rectal cancer, a prospective phase II trial	17
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis	17
Stereotactic radiosurgery for brain metastases from small cell lung cancer without prior whole-brain radiotherapy: A meta-analysis	17
On the interplay between dosiomics and genomics in radiation-induced lymphopenia of lung cancer patients	17
Low dose radiation therapy for COVID-19: Effective dose and estimation of cancer risk	17
Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma	16
MR-guided beam gating: Residual motion, gating efficiency and dose reconstruction for stereotactic treatments of the liver and lung	16
Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases	16
The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation	16
Chemical exchange saturation transfer MRI in central nervous system tumours on a 1.5 T MR-Linac	16
Study of relationship between dose, LET and the risk of brain necrosis after proton therapy for skull base tumors	16
Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy	16
Progressive muscle loss is an independent predictor for survival in locally advanced oral cavity cancer: A longitudinal study	16
Clinical use and future requirements of relative biological effectiveness: Survey among all European proton therapy centres	16
An online adaptive plan library approach for intensity modulated proton therapy for head and neck cancer	16
Dose-averaged linear energy transfer per se does not correlate with late rectal complications in carbon-ion radiotherapy	16
An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases	16
Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications	16
Advanced pencil beam scanning Bragg peak FLASH-RT delivery technique can enhance lung cancer planning treatment outcomes compared to conventional multiple-energy proton PBS techniques	16